CD4 and HIV infectious disease: Furthermore, using a combination of TLR agonist and PHA, we found that even in the presence of hyper activation, stimulation with either LPS or R848 protected CD4+ T cells from HIV infection (p > 0.0001; Supplementary Figure 12).